Genasys Inc. Reports Fiscal Second Quarter 2025 Financial Results
Entering Implementation Phase in
Initial AHD-CROWS Production Order Expected in Fiscal 2025
Richard S. Danforth, Chief Executive Officer of Genasys, Inc., commented, “The second half of fiscal 2025 is on track to see significant operational acceleration from the first six months. Planning and production of materials for the first three groups in
Continuing, Mr. Danforth said, “The deposit on the third group of dams, which was discussed on last quarter’s conference call has not yet been received. Absent the third deposit, which is expected shortly, the company sought and secured additional bridge capital of
Fiscal 2Q 2025 Financial Summary
-
Revenue of
, versus$6.9 million in 2Q 2024$5.7 million -
GAAP operating loss of
( , versus$6.3) million ( in 2Q 2024.$6.9) million -
GAAP net loss of
( versus$6.1) million ( in 2Q 2024. GAAP net loss per share ($7.0) million ) versus ($0.14 ) in 2Q 2024.$0.16 -
Adjusted EBITDA of
( , versus$5.1) million ( in 2Q 2024.$5.7) million
Business Highlights
-
Generated first revenues from
Puerto Rico dams project in fiscal 2Q 2025 - Dennis Klahn, CFO of Genasys, Inc. announced his intention to retire.
-
Amended 2024 loan agreement to secure bridge financing of
, with access to additional$4 million .$4 million -
Announced
in LRAD bookings with US Military.$2.5 million -
Received
in LRAD orders for Critical Infrastructure Protection (CIP) from the energy sector$1.0 million - Announced partnership with FloodMapp, extending the functionality of Genasys EVAC customers to better plan for and respond to flood events
Business Outlook
Genasys has begun the implementation phase of the Puerto Rico Early Warning System project, and we have a final understanding of how revenue recognition over the course of the project is going to be recorded. Planning, design, permitting and material procurement is underway for the first three groups of dams. As expected, initial revenues were recorded in the fiscal second quarter for the delivery and installation of a large generator. In the June quarter, we expect to record limited revenues from material being shipped to the island. Importantly, hardware shipment revenues will be recorded at cost. Installations will then enable profits on the material to be realized on a Percent Of Completion (POC) basis for the labor associated towards completion of each dam. Because of this accounting treatment, gross profit margins on the project will be initially suppressed, before eventually reflecting the profitability of each dam’s value upon completion.
Based on the current production and delivery schedules, and installation timelines, Genasys now expects to realize between
Despite funding uncertainty at the federal level, hardware Bookings continue to improve year over year with bookings through March up
Software bookings slowed in the March quarter. Though the software pipeline is up over
Operating Expenses in the second quarter were down roughly
The bridge financing and access to additional capital that we are announcing today is expected to provide Genasys the necessary capital to move through the
Fiscal 2Q 2025 Financial Review
Fiscal second quarter revenue was
Gross profit margin was
Operating expenses of
GAAP net loss in the quarter was
Excluding other income and expense, net income tax expense (benefit), depreciation, stock-based compensation and amortization of intangibles, Adjusted EBITDA was
Cash, cash equivalents and marketable securities totaled
We include in this press release the non-GAAP operational metrics of adjusted EBITDA, which we believe provide helpful information to investors with respect to evaluating the Company’s performance. Adjusted EBITDA represents our net loss before other income and expense, net, income tax expense (benefit), depreciation and amortization expense and stock-based compensation. We do not consider these items to be indicative of our core operating performance. The items that are non-cash include depreciation and amortization expense and stock-based compensation. Adjusted EBITDA is a measure used by management to understand and evaluate our core operating performance and trends and to generate future operating plans, make strategic decisions regarding allocation of capital and invest in initiatives that are focused on cultivating new markets for our solutions. In particular, the exclusion of certain expenses in calculating Adjusted EBITDA facilitates comparisons of our operating performance on a period-to-period basis.
Webcast and Conference Call Details
Management will host a conference call to discuss the financial results for the second quarter of fiscal year 2025 this afternoon at 4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time. To access the conference call, dial toll-free (888) 390-3967, or international at (862) 298-0702. A webcast will also be available at the following link: https://app.webinar.net/w8nZ32YLgMY
Questions to management may be submitted before the call by emailing them to: ir@genasys.com. A replay of the webcast will be available approximately four hours after the presentation on the investors page of the Company’s website.
About Genasys Inc.
Genasys Inc. (NASDAQ: GNSS) is the global leader in Protective Communications. Incorporating the most comprehensive portfolio of preparedness, response, and analytics software and systems, as well as the Company’s Long Range Acoustic Devices® (LRAD®) the Genasys Protect platform is designed around one premise: ensuring organizations and public safety agencies are “Ready when it matters™.” Protecting people and saving lives for over 40 years, Genasys covers more than 155 million people in all 50 states and in over 100 countries worldwide. For more information, visit genasys.com.
Forward-Looking Statements
Except for historical information contained herein, the matters discussed are forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. You should not place undue reliance on these statements. We base these statements on particular assumptions that we have made in light of our industry experience, the stage of product and market development as well as our perception of historical trends, current market conditions, current economic data, expected future developments and other factors that we believe are appropriate under the circumstances. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those suggested in any forward-looking statement. The risks and uncertainties in these forward-looking statements include without limitation the business impact of geopolitical conflicts and other causes that may affect our supply chain, and other risks and uncertainties, many of which involve factors or circumstances that are beyond the Company’s control. Risks and uncertainties are identified and discussed in our filings with the Securities and Exchange Commission. These forward-looking statements are based on information and management’s expectations as of the date hereof. Future results may differ materially from our current expectations. For more information regarding other potential risks and uncertainties, see the “Risk Factors” section of the Company’s Form 10-K for the fiscal year ended September 30, 2024. Genasys Inc. disclaims any intent or obligation to publicly update or revise forward-looking statements, except as otherwise specifically stated.
Genasys Inc. Consolidated Balance Sheets (Unaudited - in thousands) |
||||||||
|
|
March 31,
|
|
|
September 30,
|
|
||
|
|
(Unaudited) |
|
|
|
|
||
ASSETS |
|
|
|
|
|
|
||
Current assets: |
|
|
|
|
|
|
||
Cash and cash equivalents |
|
$ |
5,667 |
|
|
$ |
4,945 |
|
Short-term marketable securities |
|
|
1,409 |
|
|
|
7,945 |
|
Restricted cash |
|
|
95 |
|
|
|
95 |
|
Accounts receivable, net |
|
|
3,623 |
|
|
|
3,283 |
|
Inventories, net |
|
|
8,675 |
|
|
|
7,313 |
|
Prepaid expenses and other |
|
|
3,951 |
|
|
|
2,559 |
|
Total current assets |
|
|
23,420 |
|
|
|
26,140 |
|
Long-term marketable securities |
|
|
130 |
|
|
|
249 |
|
Long-term restricted cash |
|
|
585 |
|
|
|
250 |
|
Property and equipment, net |
|
|
1,279 |
|
|
|
1,291 |
|
Goodwill |
|
|
13,257 |
|
|
|
13,329 |
|
Intangible assets, net |
|
|
7,301 |
|
|
|
8,506 |
|
Operating lease right of use assets, net |
|
|
2,721 |
|
|
|
3,110 |
|
Other assets |
|
|
1,028 |
|
|
|
1,061 |
|
Total assets |
|
$ |
49,721 |
|
|
$ |
53,936 |
|
|
|
|
|
|
|
|
||
LIABILITIES AND STOCKHOLDERS' EQUITY |
|
|
|
|
|
|
||
Current liabilities: |
|
|
|
|
|
|
||
Accounts payable |
|
$ |
4,173 |
|
|
$ |
4,034 |
|
Accrued liabilities |
|
|
17,401 |
|
|
|
9,030 |
|
Operating lease liabilities, current portion |
|
|
1,047 |
|
|
|
1,021 |
|
Total current liabilities |
|
|
22,621 |
|
|
|
14,085 |
|
|
|
|
|
|
|
|
||
Notes payable, at fair value |
|
|
12,810 |
|
|
|
12,010 |
|
Warrant liability |
|
|
3,220 |
|
|
|
6,640 |
|
Long-term deferred revenue |
|
|
287 |
|
|
|
369 |
|
Operating lease liabilities, noncurrent |
|
|
2,727 |
|
|
|
3,269 |
|
Total liabilities |
|
|
41,665 |
|
|
|
36,373 |
|
|
|
|
|
|
|
|
||
Total stockholders' equity |
|
|
8,056 |
|
|
|
17,563 |
|
Total liabilities and stockholders' equity |
|
$ |
49,721 |
|
|
$ |
53,936 |
|
Genasys Inc. Consolidated Statements of Operations (Unaudited - in thousands, except per share amounts) |
||||||||||||||||
|
|
Three Months Ended
|
|
Six Months Ended
|
||||||||||||
|
|
2025 |
|
2024 |
|
2025 |
|
2024 |
||||||||
|
|
(unaudited) |
|
(unaudited) |
|
(unaudited) |
|
(unaudited) |
||||||||
Revenues |
|
$ |
6,932 |
|
|
$ |
5,739 |
|
|
$ |
13,872 |
|
|
$ |
10,100 |
|
Cost of revenues |
|
|
4,322 |
|
|
|
3,562 |
|
|
|
8,084 |
|
|
|
6,444 |
|
Gross profit |
|
|
2,610 |
|
|
|
2,177 |
|
|
|
5,788 |
|
|
|
3,656 |
|
|
|
|
37.7 |
% |
|
|
37.9 |
% |
|
|
41.7 |
% |
|
|
36.2 |
% |
Operating expenses |
|
|
|
|
|
|
|
|
||||||||
Selling, general and administrative |
|
|
6,648 |
|
|
|
6,640 |
|
|
|
13,482 |
|
|
|
13,158 |
|
Research and development |
|
|
2,217 |
|
|
|
2,531 |
|
|
|
4,502 |
|
|
|
4,722 |
|
Total operating expenses |
|
|
8,865 |
|
|
|
9,171 |
|
|
|
17,984 |
|
|
|
17,880 |
|
|
|
|
|
|
|
|
|
|
||||||||
Loss from operations |
|
|
(6,255 |
) |
|
|
(6,994 |
) |
|
|
(12,196 |
) |
|
|
(14,224 |
) |
Other income, net |
|
|
187 |
|
|
|
51 |
|
|
|
2,050 |
|
|
|
128 |
|
Loss before income taxes |
|
|
(6,068 |
) |
|
|
(6,943 |
) |
|
|
(10,146 |
) |
|
|
(14,096 |
) |
Income tax (expense) benefit |
|
|
71 |
|
|
|
(5 |
) |
|
|
71 |
|
|
|
(434 |
) |
Net loss |
|
$ |
(6,139 |
) |
|
$ |
(6,938 |
) |
|
$ |
(10,217 |
) |
|
$ |
(13,662 |
) |
|
|
|
|
|
|
|
|
|
||||||||
Net loss per common share - basic and diluted |
|
$ |
(0.14 |
) |
|
$ |
(0.16 |
) |
|
$ |
(0.23 |
) |
|
$ |
(0.31 |
) |
Weighted average common shares outstanding - basic and diluted |
|
|
45,002 |
|
|
|
44,248 |
|
|
|
44,957 |
|
|
|
44,027 |
|
|
|
|
|
|
|
|
|
|
||||||||
Reconciliation of GAAP measures to non-GAAP measures |
|
|
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
||||||||
Net loss |
|
$ |
(6,139 |
) |
|
$ |
(6,938 |
) |
|
$ |
(10,217 |
) |
|
$ |
(13,662 |
) |
Other income, net |
|
|
(187 |
) |
|
|
(51 |
) |
|
|
(2,050 |
) |
|
|
(128 |
) |
Income tax expense (benefit) |
|
|
71 |
|
|
|
(5 |
) |
|
|
71 |
|
|
|
(434 |
) |
Depreciation and amortization |
|
|
692 |
|
|
|
731 |
|
|
|
1,428 |
|
|
|
1,460 |
|
Stock based compensation |
|
|
414 |
|
|
|
524 |
|
|
|
805 |
|
|
|
970 |
|
Adjusted EBITDA |
|
$ |
(5,149 |
) |
|
$ |
(5,739 |
) |
|
$ |
(9,963 |
) |
|
$ |
(11,794 |
) |
View source version on businesswire.com: https://www.businesswire.com/news/home/20250513441083/en/
Investor Relations Contacts
Brian Alger, CFA
SVP, IR and Corporate Development
ir@genasys.com
(858) 676-0582
Source: Genasys Inc.